US · guidance
CMS Pub. 100-03, ch. 1, § 220.6.20
Beta Amyloid Positron Emission Tomography in Dementia and
Neurodegenerative Disease (RETIRED)
(Rev. 12364; Issued:11-16-23; Effective:10-13-23; Implementation:12-19-23)
Effective October 13, 2023, CMS removed NCD 220.6.20, ending CED for PET beta amyloid imaging and
permitting Medicare coverage determinations for PET beta amyloid imaging to be made by the Medicare
Administrative Contractors under section 1862(a)(1)(A) of the Social Security Act.
History
(Rev. 12364; Issued:11-16-23; Effective:10-13-23; Implementation:12-19-23)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
7b873a9425def512415510adce609440d14fe1f581aa94b7c1fb87ce3df78cf5
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.